Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2980124 | The Journal of Thoracic and Cardiovascular Surgery | 2015 | 12 Pages |
Abstract
In patients undergoing AVR with coexistent CAD, concomitant CABG reduces risk of late death by more than one-third, without augmenting operative mortality. This survival advantage persists in moderate (50% to 70%) and severe (>70%) CAD. These findings underline the prognostic importance of revascularization in this population and should influence decisions regarding revascularization strategy in patients undergoing transcatheter valve therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Nassir M. MBChB, Rakesh M. MD, DPhil, Richard C. MD, Kevin L. MD, Joseph A. MD, John M. MD, Lyle D. MD, Harold M. MD, Alberto MD, Zhuo MSc, Robert L. MD, Hartzell V. MD,